REVERSAL OF BENZODIAZEPINE SEDATION WITH THE ANTAGONIST FLUMAZENIL

Open Access
Publisher Website
Google Scholar
Abstract
The effectiveness of the benzodiazepine antagonist flumazenil, was evaluated in a randomized double-blind clinical study in which diazepam 0.2 mg kg−1 or midazolam 0.1 mg kg−1 was used for i.v. sedation. We studied 120 day-case patients undergoing gastroscopy and treated with either flumazenil 0.1–2 mg or placebo after the procedure. Psychometric assessment of four aspects of recovery over a 3-h period showed that flumazenil attenuated the sedative effects of the benzodiazepines, but did not antagonize the sedation completely. For patients sedated with diazepam, there was a significant effect of flumazenil on speed of motor co-ordination after 90 min (P < 0.01), and for those given midazolam a similar effect was found at 20 min (P < 0.01). However, after 3 h all four groups of patients had not returned to baseline performance in accuracy of motor co-ordination (P < 0.01) and cortical arousal (P < 0.05), and the two groups sedated with diazepam still displayed memory deficits (P < 0.05). Flumazenil did not attenuate the subjective experience of sedation as measured by visual analogue scales. These results indicate that sedation is multidimensional, differentially affecting the hierarchy of cognitive functions. In day-cases, antagonism of benzodiazepine sedation with flumazenil would not hasten the safe discharge of patients.

This publication has 0 references indexed in Scilit: